Stock listing

LSE:GDR Genedrive PLC Share Price

Home listing (LSE) of Genedrive PLC

Follow Genedrive PLC into a list and get an email when it puts out news.

Share price · LSE:GDR

0.85p GBX (pence) -0.05 (-5.6%)

Close on Nov 20, 2026

Past year -10.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
0.80p – 0.90p GBX (pence)Nov 20, 2026
Volume
5.38M sharesNov 20, 2026
Market cap
£13.65M GBPAt the close on Nov 20, 2026 · price × 1.61B shares outstanding
52-week range
0.715p – 1.55p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£40,102 GBPMedian day 2.62M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Genedrive PLC logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:GDR · Home0.85p GBX (pence)-0.05 (-5.6%)5,383,6240.90p0.90p0.80p0.90pClose on Nov 20, 2026
Frankfurt:D6M€0.01 EUR0.00 (0.0%)—€0.01€0.01€0.01€0.01Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:GDR · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
0.85p-0.05-5.6%0.90p0.90p0.80p5,383,624
0.90p0.000.0%0.90p0.90p0.875p2,487,950
0.90p0.000.0%0.90p0.95p0.85p63,256
0.90p0.000.0%0.90p0.95p0.85p700,451
0.90p0.000.0%0.90p0.95p0.876p1,913,919
0.90p0.000.0%0.90p0.95p0.878p1,522,574
0.90p+0.025+2.9%0.875p0.95p0.85p2,470,801
0.875p0.000.0%0.875p0.95p0.85p4,134,101
0.875p0.000.0%0.875p0.95p0.85p2,586,669
0.875p-0.10-10.3%0.95p1.00p0.855p7,820,117
0.975p0.000.0%0.95p1.00p0.95p3,273,022
0.975p+0.025+2.6%0.95p1.00p0.93p4,286,562
0.95p-0.025-2.6%0.975p1.00p0.90p2,070,055
0.975p0.000.0%0.975p1.00p0.965p2,351,199
0.975p0.000.0%0.975p1.00p0.965p1,288,163
0.975p-0.025-2.5%1.00p1.05p0.965p2,013,639
1.00p0.000.0%1.00p1.05p0.95p2,395,494
1.00p-0.025-2.4%1.025p1.05p0.945p2,447,416
1.025p-0.075-6.8%1.095p1.095p1.00p3,635,750
1.10p+0.025+2.3%1.075p1.15p1.033p2,898,418
1.075p0.000.0%1.075p1.09p1.031p227,983
1.075p0.000.0%1.075p1.15p1.03p225,567
1.075p0.000.0%1.075p1.14p1.00p678,594
1.075p+0.025+2.4%1.05p1.15p1.00p1,269,451
1.05p-0.05-4.5%1.10p1.12p1.01p4,359,996
1.10p+0.05+4.8%1.10p1.15p1.05p1,230,437
1.05p-0.025-2.3%1.075p1.15p1.05p1,150,153
1.075p-0.025-2.3%1.10p1.15p1.075p3,525,214
1.10p-0.05-4.3%1.20p1.20p1.05p4,919,486
1.15p0.000.0%1.15p1.173p1.122p432,345
1.15p0.000.0%1.15p1.18p1.10p1,865,891
1.15p-0.025-2.1%1.175p1.25p1.10p2,157,812
1.175p0.000.0%1.175p1.25p1.125p2,619,985
1.175p0.000.0%1.175p1.20p1.116p3,805,447
1.175p-0.025-2.1%1.20p1.25p1.15p2,606,746
1.20p0.000.0%1.20p1.25p1.15p2,827,987
1.20p+0.025+2.1%1.175p1.25p1.15p4,228,550
1.175p-0.025-2.1%1.20p1.233p1.15p3,329,222
1.20p0.000.0%1.20p1.25p1.10p6,253,554
1.20p+0.025+2.1%1.175p1.24p1.15p2,145,325
1.175p-0.025-2.1%1.20p1.25p1.15p3,603,057
1.20p+0.05+4.3%1.175p1.25p1.15p2,881,128
1.15p-0.075-6.1%1.20p1.25p1.15p1,498,355
1.225p-0.025-2.0%1.225p1.25p1.20p6,344,456
1.25p0.000.0%1.25p1.30p1.20p5,738,171
1.25p0.000.0%1.25p1.29p1.20p3,249,872
1.25p0.000.0%1.225p1.30p1.20p1,905,939
1.25p-0.025-2.0%1.275p1.30p1.20p3,852,365
1.275p-0.025-1.9%1.30p1.35p1.25p1,553,849
1.30p0.000.0%1.30p1.35p1.27p12,222,263
1.30p-0.025-1.9%1.40p1.40p1.25p1,067,251
1.325p+0.025+1.9%1.30p1.35p1.25p6,346,424
1.30p-0.05-3.7%1.35p1.375p1.255p3,653,041
1.35p-0.025-1.8%1.375p1.45p1.30p3,136,892
1.375p0.000.0%1.375p1.45p1.30p1,612,694
1.375p0.000.0%1.375p1.50p1.30p11,258,889
1.375p-0.025-1.8%1.40p1.45p1.30p1,115,429
1.40p0.000.0%1.40p1.55p1.35p10,964,144
1.40p+0.075+5.7%1.325p1.40p1.25p4,942,826
1.325p0.000.0%1.325p1.40p1.25p777,076
1.325p+0.025+1.9%1.30p1.40p1.25p864,851
1.30p-0.08-5.8%1.375p1.40p1.25p3,125,127
1.38p+0.08+6.2%1.30p1.40p1.25p12,404,644
1.30p-0.05-3.7%1.35p1.40p1.26p5,229,933
1.35p+0.10+8.0%1.25p1.40p1.245p5,533,595
Ticker
LSE:GDR
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LSE
Currency
GBX

What changed lately

Calls

Replays

  • Genedrive (LSE:GDR) — Full year results briefing

    Mon, Dec 08, 2025 · 9:00 AM ET

    Watch Transcript
  • Genedrive (LSE:GDR) — Full year results briefing

    Mon, Dec 02, 2024 · 9:00 AM ET

    Watch Transcript
  • Genedrive (LSE:GDR) — Interim results presentation

    Fri, Apr 05, 2024 · 5:00 AM ET

    Watch Transcript

Latest news

ShareSoc Investor Presentation Reminder

Sep 3, 2026

Closed 1.38p (0.0%) on Sep 3, 2026

Director/PDMR Notification

Sep 1, 2026

Closed 1.40p (0.0%) on Sep 1, 2026

Board Appointments

Aug 21, 2026

Closed 1.30p (-3.7%) on Aug 21, 2026

ShareSoc Investor Presentation

Aug 13, 2026

Closed 1.20p (0.0%) on Aug 13, 2026

Completion of PALOH-UK Patient Recruitment

Aug 11, 2026

Closed 1.20p (+4.3%) on Aug 11, 2026

MT-RNR1 test implemented in the Netherlands

Aug 4, 2026

Closed 1.15p (+15.0%) on Aug 4, 2026

All Genedrive PLC news

Financings

  • Private placement of placing Shares

    Feb 19, 2026 · US$681,872

    Update: £500,000 · GBX 1 a share · Peel Hunt LLP

    Dealers: Peel Hunt LLP (lead)

    Update Feb 13, 2026 · Update Feb 19, 2026

  • Private placement of firm Subscription Shares

    Feb 19, 2026 · US$4.77M

    Tranche closed: £3.5M raised · GBX 1 a share

    Update Feb 13, 2026 · Tranche closed Feb 19, 2026

  • Rights offering of open Offer Shares

    Feb 19, 2026 · US$2.02M

    Update: up to £1.5M · GBX 1 a share · Peel Hunt LLP

    Dealers: Peel Hunt LLP (lead)

    Buyers: Dr. Gino Miele (intends to subscribe for £50,000 worth of Open Offer Shares); Russ Shaw (intends to subscribe for £50,000 worth of Open Offer Shares)

    Insiders: CEO Dr. Gino Miele and CFO Russ Shaw each intend to subscribe for £50,000 worth of Open Offer Shares

    Update Feb 13, 2026 · Update Feb 19, 2026

  • New equity (institutional placing and open offer)

    Jan 19, 2026 · US$8.05M

    Announced: up to £6M

    Buyers: David Nugent (intends to subscribe for £1.5m); Robert English (intends to subscribe for £1.5m)

    Insiders: The Directors intend to invest not less than £100,000 in the Equity Raise; major shareholders David Nugent and Robert English intend to subscribe £1.5m each.

    Use of proceeds: Commercialisation and market expansion in UK, Europe and Middle East, FDA 510(k) submission, manufacturing scale-up, product refinements and IP translation

    Announced Jan 19, 2026

  • Secured shareholder loan

    Dec 9, 2025

    Update: debt

    Buyers: David Nugent (Lender of up to £1.0 million; intends to convert all drawn amounts into equity as part of a future equity raise)

    Insiders: Loan provided by David Nugent, a significant shareholder and related party; constitutes a related party transaction under AIM Rule 13

    Use of proceeds: Extend the Company's cash runway into February 2026

    Update Dec 9, 2025

  • Private placement of new ordinary shares (Placing Shares)

    Oct 9, 2025

    Update: GBX 0.2 a share · 1 warrant at GBX 0.4 for 24 months · Peel Hunt LLP +1

    Dealers: Peel Hunt LLP (co-lead), Allenby Capital Limited (co-lead)

    Use of proceeds: Extend cash runway into Q2/Q3 2026, drive sales and move closer to potential launch in other markets including the US

    Announced Sep 23, 2025 · Update Sep 29, 2025 · Update Oct 9, 2025

  • New ordinary shares (Retail Offer Shares)

    Sep 23, 2025 · US$405,581

    Announced: £300,000 · GBX 0.2 a share · 1 warrant at GBX 0.4 for 24 months · Allenby Capital Limited

    Dealers: Allenby Capital Limited (lead)

    Announced Sep 23, 2025

  • Private placement of new Ordinary Shares

    Apr 1, 2025

    Closed: £1.23M raised · GBX 1.5 a share · free to trade Apr 3, 2025

    Closed Apr 1, 2025

Read by 6ix AI from the company's releases

Decks

Genedrive PLC on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
34 in the last 12 months · 284 in all · newest Oct 12, 2026 · oldest 2007
Calls
9 calls with a replay · 9 with a transcript · latest Dec 8, 2025
Decks
4 decks · latest September 2026

Where Genedrive PLC is listed

ListingExchangeCountryCurrency
LSE:GDR · Home listing · This pageLSEUnited KingdomGBX
Aquis:GDRLAquisUnited KingdomGBX
Frankfurt:D6MFrankfurtGermanyEUR
Stuttgart:D6MStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Genedrive PLC.